Lightwave Logic Completes Fabrication of Prototype Phase Modulator

Lightwave Logic, Inc. (OTC Bulletin Board: LWLG) a technology company focused on the development of electro-optic polymer materials for applications in high speed fiber-optic telecommunications and optical computing, today announced the successful completion of the fabrication stage of their prototype phase modulator, demonstrating a commercially viable process for the manufacture of optical devices using Lightwave's 'Next Generation Electro-Optic Material Platform.'

This multi-step manufacturing process involved exposing its proprietary Perkinamine material to extreme conditions that are found in standard commercial manufacturing settings. A step-by-step analysis throughout the fabrication process showed that Lightwave's proprietary material can successfully withstand each step of the manufacturing process without damage. With the help of its strategic partner Photon-X, LLC, the first run of the fabrication process yielded 100 individual prototype Phase Modulators.

These proof-of-principle prototype Phase Modulators, which were produced in concert with our strategic partner, are in the process of being optically and electrically interconnected for electrical and optical performance testing. The large number of electro-optic devices produced provides the opportunity to measure for statistical verification.

"We are very encouraged by the results of our fabrication campaign in the last few weeks," said Dr. David Eaton, CTO of Lightwave Logic. "The performance of our material during the stresses of the various fabrication processes pleased us and our partner Photon-X".

"We believe we have reached a significant milestone on the road to the commercialization of our 'Next Generation Electro-Optic Material Platform,'" stated Jim Marcelli, Lightwave Logic's CEO, "'Powered by Lightwave Logic' is our vision and our goal as we target the Telecommunications, Computer and Military Aerospace industries' wide array of products in those multi-billion dollar markets."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.